Loading...
•
Mar 31, 2021
Bio-Techne Q3 2021 Earnings Report
Bio-Techne's Q3 2021 results were released, showcasing revenue growth and margin expansion.
Key Takeaways
Bio-Techne reported a strong third quarter in fiscal year 2021, with a 25% increase in net sales to $243.6 million and organic growth of 22%. The company's adjusted operating margin improved to 40.1%, and adjusted EPS increased by 29% to $1.79.
Third quarter organic revenue increased by 22% to $243.6 million.
GAAP EPS was $1.12, compared to $0.92 in the same quarter last year.
Adjusted EPS was $1.79, an increase of 29% compared to $1.39 in the same quarter last year.
Adjusted Operating Margin increased to 40.1% compared to 36.4% in the third quarter of fiscal 2020.
Bio-Techne
Bio-Techne
Bio-Techne Revenue by Segment
Revenue by Segment
Protein Sciences Revenue
CapyFin.comDiagnostics & Spatial Bio Revenue
CapyFin.com Forward Guidance
The company did not provide specific forward guidance in this earnings report.
Revenue & Expenses
Visualization of income flow from segment revenue to net income